Improving and assuring newborn screening laboratory quality worldwide: 30-year experience at the Centers for Disease

Víctor R De Jesús1, Joanne V Mei, Carol J Bell

  • 1Newborn Screening Quality Assurance Program, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA. vdejesus@cdc.gov

Insights

The Centers for Disease Control and Prevention

Area of Science:

  • Public Health
  • Genetics
  • Clinical Diagnostics

Background:

  • Newborn screening is a critical public health initiative in the U.S. for detecting inherited congenital disorders.
  • Accurate and timely screening is essential to prevent long-term health issues in infants.
  • The Centers for Disease Control and Prevention (CDC) plays a vital role in ensuring the quality of these screening programs.

Purpose of the Study:

  • To review the milestones and services of the CDC's Newborn Screening Quality Assurance Program.
  • To highlight the program's contribution to accurate and high-quality newborn screening.
  • To underscore the program's role in supporting laboratories nationwide and globally.

Main Methods:

  • The report reviews historical data and program evolution over 30 years.
  • It details the services provided to enhance laboratory performance in newborn screening.
  • Analysis of program growth in terms of disorders screened and participant laboratories.

Main Results:

  • The CDC's Newborn Screening Quality Assurance Program has successfully supported screening for over 4 million infants annually.
  • The program has expanded significantly, covering more than 50 disorders compared to 1 in 1978.
  • It has consistently ensured accurate detection, minimized false positives, and maintained high-quality performance for participating laboratories.

Conclusions:

  • The CDC's Newborn Screening Quality Assurance Program is a cornerstone of public health, safeguarding infant health through reliable genetic screening.
  • The program's sustained growth and comprehensive services demonstrate its effectiveness and importance to the newborn screening community.
  • Continued support and evolution of this program are crucial for addressing the challenges of inherited disorders in newborns.

Related Concept Videos

Quality Control01:05

Quality Control

Quality control is one of the three cyclical quality assurance activities that help keep a system under statistical control. Typical quality control activities include creating quality control charts, conducting proficiency testing, and documenting and archiving results.
Quality control helps track data, visualize trends, and identify variations, making it easier to detect deviations that may affect the accuracy of an analysis. One way to do this is by generating a quality control chart, which...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...